Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2010 1
2017 2
2018 4
2019 2
2020 1
2021 5
2022 9
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.
Gutierrez-Sainz L, Martinez-Fdez S, Pedregosa-Barbas J, Peña J, Alameda M, Viñal D, Villamayor J, Martinez-Recio S, Perez-Wert P, Pertejo-Fernandez A, Gallego A, Martinez-Marin V, Zamora P, Espinosa E, Mendiola M, Feliu J, Redondo A. Gutierrez-Sainz L, et al. Among authors: gallego a. Clin Transl Oncol. 2023 Dec;25(12):3519-3526. doi: 10.1007/s12094-023-03221-6. Epub 2023 Jun 17. Clin Transl Oncol. 2023. PMID: 37329429
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Cueva JF, Palacio I, Churruca C, Herrero A, Pardo B, Constenla M, Santaballa A, Manso L, Estévez P, Maximiano C, Legerén M, Marquina G, de Juan A, Quindós M, Sánchez L, Barquin A, Fernández I, Martín C, Juárez A, Martín T, García Y, Yubero A, Gallego A, Martínez Bueno A, Guerra E, González-Martín A. Cueva JF, et al. Among authors: gallego a. Eur J Cancer. 2023 Mar;182:3-14. doi: 10.1016/j.ejca.2022.12.023. Epub 2022 Dec 29. Eur J Cancer. 2023. PMID: 36706655
Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features.
Spagnolo E, Martinez A, Mascarós-Martínez A, Marí-Alexandre J, Carbonell M, González-Cantó E, Pena-Burgos EM, Mc Cormack BA, Tomás-Pérez S, Gilabert-Estellés J, López-Carrasco A, Hidalgo P, Ángeles MA, Redondo A, Gallego A, Hernández A. Spagnolo E, et al. Among authors: gallego a. Int J Mol Sci. 2023 Jul 28;24(15):12083. doi: 10.3390/ijms241512083. Int J Mol Sci. 2023. PMID: 37569458 Free PMC article.
Dostarlimab for the treatment of advanced endometrial cancer.
Redondo A, Gallego A, Mendiola M. Redondo A, et al. Among authors: gallego a. Expert Rev Clin Pharmacol. 2022 Jan;15(1):1-9. doi: 10.1080/17512433.2022.2044791. Epub 2022 Feb 22. Expert Rev Clin Pharmacol. 2022. PMID: 35184615
Current status of deepwater oil spill modelling in the Faroe-Shetland Channel, Northeast Atlantic, and future challenges.
Gallego A, O'Hara Murray R, Berx B, Turrell WR, Beegle-Krause CJ, Inall M, Sherwin T, Siddorn J, Wakelin S, Vlasenko V, Hole LR, Dagestad KF, Rees J, Short L, Rønningen P, Main CE, Legrand S, Gutierrez T, Witte U, Mulanaphy N. Gallego A, et al. Mar Pollut Bull. 2018 Feb;127:484-504. doi: 10.1016/j.marpolbul.2017.12.002. Epub 2017 Dec 21. Mar Pollut Bull. 2018. PMID: 29475689 Free article. Review.
Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer.
Mendiola M, Pellinen T, Ramon-Patino JL, Berjon A, Bruck O, Heredia-Soto V, Turkki R, Escudero J, Hemmes A, Garcia de la Calle LE, Crespo R, Gallego A, Hernandez A, Feliu J, Redondo A. Mendiola M, et al. Among authors: gallego a. Mod Pathol. 2022 Feb;35(2):256-265. doi: 10.1038/s41379-021-00930-7. Epub 2021 Oct 12. Mod Pathol. 2022. PMID: 34642425 Free article.
Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
Ramon-Patino JL, Ruz-Caracuel I, Heredia-Soto V, Garcia de la Calle LE, Zagidullin B, Wang Y, Berjon A, Lopez-Janeiro A, Miguel M, Escudero J, Gallego A, Castelo B, Yebenes L, Hernandez A, Feliu J, Pelaez-García A, Tang J, Hardisson D, Mendiola M, Redondo A. Ramon-Patino JL, et al. Among authors: gallego a. Cancers (Basel). 2022 Feb 12;14(4):912. doi: 10.3390/cancers14040912. Cancers (Basel). 2022. PMID: 35205661 Free PMC article.
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer.
Gallego A, Mendiola M, Hernando B, Berjon A, Cadiz A, Chaves-Urbano B, Heredia-Soto V, Spagnolo E, Hernández Gutiérrez A, Hardisson D, Macintyre G, Redondo A, Garcia MJ. Gallego A, et al. Int J Gynecol Cancer. 2022 Aug 1;32(8):1009-1016. doi: 10.1136/ijgc-2022-003353. Int J Gynecol Cancer. 2022. PMID: 35437272
Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models.
Heredia-Soto V, Escudero J, Miguel M, Ruiz P, Gallego A, Berjón A, Hernández A, Martínez-Díez M, Zheng S, Tang J, Hardisson D, Feliu J, Redondo A, Mendiola M. Heredia-Soto V, et al. Among authors: gallego a. Front Oncol. 2022 Mar 17;12:862321. doi: 10.3389/fonc.2022.862321. eCollection 2022. Front Oncol. 2022. PMID: 35372006 Free PMC article.
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study.
Fernández-Serra A, López-Reig R, Márquez R, Gallego A, de Sande LM, Yubero A, Pérez-Segura C, Ramchandani-Vaswani A, Barretina-Ginesta MP, Mendizábal E, Esteban C, Gálvez F, Sánchez-Heras AB, Guerra-Alía EM, Gaba L, Quindós M, Palacio I, Alarcón J, Oaknin A, Aliaga J, Ramírez-Calvo M, García-Casado Z, Romero I, López-Guerrero JA. Fernández-Serra A, et al. Among authors: gallego a. Cancers (Basel). 2023 Jun 1;15(11):3030. doi: 10.3390/cancers15113030. Cancers (Basel). 2023. PMID: 37296992 Free PMC article.
28 results